A meta-analysis and morphological review of cyclosporine-induced nephrotoxicity in auto-immune diseases

Kidney International

Volumn 54, Issue 2, 1998, Pages 536-545

  Vercauteren, Sven B ^a   Bosmans, Jean Louis ^a   Elseviers, Monique M ^a   Verpooten, Gert A ^a   De Broe, Marc E ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Acute nephrotoxicity; Chronic nephrotoxicity; Crohn's disease; Cyclosporine A; Psoriasis; Renal biopsy; Rheumatoid arthritis; Risk difference; Serum creatinine

Indexed keywords

AZATHIOPRINE; CHLOROQUINE; CREATININE; CYCLOSPORIN A; ETRETINATE; PENICILLAMINE; PLACEBO;

ARTICLE; AUTOIMMUNE DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HUMAN; KIDNEY BIOPSY; META ANALYSIS; MORPHOLOGY; NEPHROTOXICITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS;

EID: 0031854280     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00017.x     Document Type: Article

References (85)

1. BOREL JF, FEURER C, GOBLET HV: Biological effects of cyclosporin A, a new antilymphocytic agent. Agents Actions 6:468-475, 1976
2. MERION RM, WHITE DJG, THIRU S: Cyclosporine: Five years' experience in cadaveric renal transplantation. N Engl J Med 310:148-154, 1984
3. KAHAN BD: Cyclosporine: The hase for immunosuppressive therapy present and future. Transplant Proc 25:508-510, 1993
4. ELLIS CN, GORSULOWSKY DC, HAMILTON TA, BILLINGS JK, BROWN MD, HEADINGTON JT, COOPER KD, BAADSGAARD O, DUELL EA, ANNESLEY TM, TURCOTTE JG, VOORHEES JJ: Cyclosporine improves psoriasis in a double-blind study. JAMA 256:3110-3116, 1986
5. GRIFFITHS CEM, POWLES A, LEONARD J, FRY L: Clearance of psoriasis with low dose cyclosporin. BMJ 293:731-732, 1986
6. VAN JOOST T, STOLZ E, HEULE F: Efficacy of low-dose cyclosporine in severe atopic skin disease. Arch Dermatol 123:166-167, 1987
7. BROWN MD, ELLIS CN, VOORHEES JJ: Cyclosporine A: A review of its dermatologic applications. Semin Dermatol 6:2-9, 1987
8. PALESTINE AG, AUSTIN HA, BALOW JE, ANTONOVYCH TT, SABNIS SG, PREUSS HG, NUSSENBLATT RB: Renal histopathologic alterations in patients treated with cyclosporine for uveitis. N Engl J Med 314: 1293-8, 1986
9. VAN RIJTHOVEN AWAM, DIJKMANS BAC, GOEI THÈ HS, HERMANS J, MONTNOR-BECKERS ZLMB, JACOBS PCJ, CATS A: Cyclosporin treatment for rheumatoid arthritis: A placebo controlled, double blind, multicentre study. Ann Rheum Dis 45:726-731, 1986
10. BRYNSKOV J, FREUND L, RASMUSSEN SN, LAURITSEN K, SCHAFFALITZKY DE MUCKADELL O, WILLIAMS N, MACDONALD AS, TANTON R, MOLINA F, CAMPANINI MC, BIANCHI P, RANZI T, QUARTO DI PAULO F, MALCHOW-MΦLLER A, ØSTERGAARD THOMSEN O, TAGE-JENSEN U, BINDER V, RIIS P: A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease. N Engl J Med 321:845-850, 1989
11. WIESNER RH, LUDWIG, J, LINDOR KD, JORGENSEN RA, BALDUS WP, HOMBURGER HA, DICKSON ER: A controlled trial of cyclosporine in the treatment of primary billiary cirrhosis. N Engl J Med 322:1419-1424, 1990
12. THE MULTIPLE SCLEROSIS STUDY GROUP: Efficacy and toxicity of cyclosporine in chronic progressive multiple sclerosis: A randomized, double-blinded, placebo-controlled clinical trial. Ann Neurol 27:591-605, 1990
13. ZACHARIAK H, HALKIER-SORENSEN L, HEICKENDORFF L, ZACHARIAE E, HANSEN HE: Cyclosporin A treatment of systemic sclerosis. Br J Dermatol 122:677-681, 1990
14. TINDALL RSA, ROLLINS JA, PHILLIPS JT, GREENLEE RG, WELLS L, BELENDIJK G: Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis. N Engl J Med 316:719-724, 1987
15. MEYRIER A: Treatment of glomerular disease with Cyclosporin A. Nephrol Dial Transplant 4:923-931, 1989
16. FEUTREN G, PAPOZ L, ASSAN R, VIALETTES B, KARSENTY G, VEXIAU P, Du ROSTU H, RODIER M, SIRMAI J, LALLEMAND A: Cyclosporine increases the rate and length of remissions in insuline-dependent diabetes of recent onset. Lancet 2:119-124, 1986
17. RADHAKRISHNAN J, KUNIS CL, D'AGATI V, APPEL GB: Cyclosporine treatment of lupus membranous nephropathy. Clin Nephrol 42:147-154, 1994
18. RUIZ P, KOLBECK PC, SCROGGS MW, SANFLIPPO F: Associations between cyclosporine therapy and interstitial fibrosis in renal allograft biopsies. Transplantation 45:91-95, 1988
19. FIORETTO P, STEFFES MW, MIHATSCH MJ, STROM EH, SUTHERLAND DE, MAUER M: Cyclosporine associated lesions in native kidneys of diabetic pancreas transplant patients. Kidney Int 48:489-495, 1995
20. HIGGINS E, MUNRO C, MARKS J, FRIEDMANN PS, SHUSTER S: Relapse rates in moderately severe chronic psoriasis treated with Cyclosporin A. Br J Dermatol 121:71-74, 1989
21. INTERNATIONAL KIDNEY BIOPSY REGISTRY OF CYCLOSPORIN (SANDIMMUN®) IN AUTOIMMUNE DISEASES: Renal morphology after Cyclosporin A therapy in rheumatoid arthritis patients. Br J Rheum 32(Suppl 1):65-71, 1993
22. MIHATSCH MJ, WOLFF K: Consensus conference on cyclosporin A for psoriasis (February 1992). Br J Dermatol 126:621-623, 1992
23. PANAYI GS, TUGWELL P: The use of cyclosporin A in rheumatoid arthritis: Conclusions of an international review. Br J Rheumatol 33:967-969, 1994
24. COCHRAN WG: The combination of estimates from different experiments. Biometrics 10:101-129, 1954
25. DERSIMONIAN R, LAIRD N: Meta-analysis in clinical trials. Controlled Clin Trials 7:177-188, 1986
26. COPLEN SE, ANTMAN EM, BERLIN JA, HEWITT P, CHALMERS TC: Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. Circulation 82:1106-1116, 1990
27. EDWARDS BD, CHALMERS RJG, O'DRISCOLL JB, MITCHELL DM, SMITH RJ, LAWSON RS, TESTA HJ, BALLARDIE FW: Angiotensin II as a risk factor for cyclosporin nephrotoxicity in patients with psoriasis. Clin Nephrol 41:350-356, 1994
28. LEVELL NJ, SHUSTER S, MUNRO CS, FRIEDMANN PS: Remission of ordinary psoriasis following a short clearance course of cyclosporin. Acta Derm Venereol (Stockh) 75:65-69, 1995
29. REITAMO S, ERKKO P, REMITZ A, LAUERMA AI, MONTONEN O, HARJULA K: Cyclosporine in the treatment of palmoplantar pustolosis. A randomized, double-blind, placebo-controlled study. Arch Dermatol 129:1273-1279, 1993
30. SNOWDEN JM, BERTH-JONES J, Ross JS, MOTLEY RJ, MARKS R, FINLAY YA, SALEK MS, GRAHAM-BROWN RAC, ALLEN BR, CAMP RDR: Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis. Lancet 338:137-140, 1991
31. BEN EZRA D, COHEN E, CHAJEK T, FRIEDMAN G, PIZANTI S, DE COURTEN C, HARRIS W: Evaluation of conventional therapy versus cyclosporine A in Behçet's syndrome. Transplant Proc 20(Suppl 3):S136-S143, 1988
32. FΦRRE Ø, BJERKHOEL F, SALVESEN CF, BERG KJ, RUGSTAD HE, SAELID G, MELLBYE OJ, KASS E: An open, controlled, randomized comparison of cyclosporine and azathioprine in the treatment of rheumatoid arthritis: a preliminary report. Arthritis Rheum 30:88-92, 1987
33. MASUDA K, NAKAJIMA A, URAYAMA A, NAKAE K, KOGURE M, INABA G: Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease. Lancet 1:1093-1096, 1989
34. NUSSENBLATT RB, PALESTINE AG, CHAO CHAN C, STEVENS G JR, MELLOW SD, GREEN SB: Randomized, double-masked study of cyclosporine compared to prednisolone in the treatment of endogenous uveitis. Am J Ophtalmol 112:138-146, 1991
35. BOERS M, BENSEN WG, LUDWIN D, GOLDSMITH CH, TUGWELL P: Cyclosporine nephrotoxicity in rheumatoid arthritis: No effect of short term misoprostol treatment. J Rheumatol 19:534-537, 1992
36. ELLIS CN, FRADIN MS, MEESSANA JM, BROWN MD, SIEGEL MT, HARTLEY AH, ROCHER LL, WHEELER S, HAMILTON TA, PARISH TG, ELLIS-MADU M, DUELL E, ANNESLY T, COOPER KD, VOORHEES JJ: Cyclosporine for plaque-type psoriasis. N Engl J Med 324:277-284, 1991
37. ELLIS CN, FRADIN MS, HAMILTON TA, VOORHEES JJ: Duration of remission during maintenance cyclosporine therapy for psoriasis. Arch Dermatol 131:791-795, 1995
38. LICHTIGER S, PRESENT DH, KORNBLUTH A, GELLERNT I, BAUER J, GALLER G, MICHELASSI F, HANAUER S: Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 330:1841-1845, 1994
39. NUSSENBLATT RB, DE SMET MD, RUBIN B, FREIDLIN V, WHITCUP SM, DAVIS J, HERMAN D, BLOOM JN, SRAN PK, WHITCHER S, PALESTINE A, AUSTIN H: A masked, randomized, dose-response study between cyclosporine A and g in the treatment of sight-threatening uveitis of non-infectious origin. Am J Ophtalmol 115:583-591, 1993
40. TUGWELL P, PINGUS T, YOCUM D, STEIN M, GLUCK O, KRAAG G, MCKENDRY R, TESSER J, BAKER P, WELLS G: Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. N Engl J Med 333:137-141, 1995
41. WEINBLATT ME, GERMAIN BF, KREMER JM, WALL BA, WEISMAN MH, MAIER AL, COBLYN JS: Lack of renal protective effect of misoprostol in rheumatoid arthritis patients receiving cyclosporin A. Arthritis Rheum 37:1321-1325, 1994
42. VAN JOOST TH, BOS JD, HEULE F, MEINARDI MMHM: Low-dose cyclosporin A in severe psoriasis. A double-blind study. Br J Dermatol 118:183-190, 1988
43. VAN RIJTHOVERN AW, DIJKMANS BA, GOEI THÈ H, MEIJERS KAE, MONTNOR-BECKERS ZLBM, MOOLENBURGH JD, BOERS M, CATS A: Comparison of cyclosporin and d-penicillamine for rheumatoid arthritis: A randomized double blind multicenter study. J Rheumatol 18:815-820, 1991
44. STYANGE EF, MODIGLIANI R, PENA AS, WOOD AJ, FEUTREN G, SMITH PR, THE EUROPEAN STUDY GROUP: European trial of cyclosporine in chronic active Crohn's disease: A 12-month study, Gastroenterology 109:774-782, 1995
45. NICHOLLS S, DOMIZIO P, WILLIAMS CB, DAWNEY A, BRAEGGER CP, MACDONALD TT, WALKER-SMITH JA: Cyclosporin as initial treatment for Crohn's disease. Arch Dis Child 71:243-247, 1994
46. ÖZYAZGAN Y, YURDAKUL S, YAZICKI H, TÜZÜN B, ISÇIMEN A, TÜZÜN Y. AKTUNC T, PAZARLI H, HAMURYUDAN V, MÜFTÜOGLU A: Low dose cyclosporin A versus pulsed cyclophosphamide in Behçet's syndrome: A single masked trial. Br J Ophtalmol 76:241-243, 1992
47. AHERN MJ, HARRISON W, HOLLINGSWORTH P, BRADLEY J, LAING, B, BAYLISS C: A randomised double-blind trial of cyclosporin and azathioprine in refractory rheumatoid arthritis. Aust NZ J Med 21:844-849, 1991
48. BERG KJ, FΦRRE Ø, BJERKHOEL F, AMUNDSEN E, DJΦSELAND O, RUGSTAD HE, WESTRE B: Side effects of cyclosporin A treatment in patients with rheumatoid arthritis. Kidney Int 29:1180-1187, 1986
49. BERG KJ, FΦRRE Ø, DJΦSELAND O, MIKKELSEN M, NAVERUD J, RUGSTAD HE: Renal side effects of high and low cyclosporin A doses in patients with rheumatoid arthritis. Clin Nephrol 31:232-238, 1989
50. BOERS M, DIJKMANS BAC, VAN RIJTHOVEN AWAM, GOEI THÉ HS, CATS A: Reversible nephrotoxicity of cyclosporine in rheumatoid arthritis. J Rheumatol 17:38-42, 1990
51. DE VRIES J, BAARSMA GS, ZAAL MJW, BOEN-TAN TN, ROTHOVA A, BUITENHUIS HJ, SCHWEITZER CMC, DE KEIZER RJW, KIJLSTRA A: Cyclosporin in the treatment of severe chronic idiopathic uveitis. Br J Ophtalmol 74-344-349, 1990
52. DIJKMANS BAC, VAN RIJTHOVEN AWAM, GOEI THÈ HS, MONTNORBECKERS ZLBM, JACOBS PCJ, CATS A: Effect of cyclosporine on serum creatinine in patients with rheumatoid arthritis. Eur J Clin Pharmacol 31:541-545, 1987
53. DOUGADOS M, AWADA H, AMOR B: Cyclosporin in rheumatoid arthritis: A double blind, placebo-controlled study in 52 patients. Ann Rheum Dis 47:127-133, 1988
54. FEAGAN BG, MCDONALD JWD, ROCHON J, LAUPACIS A, FEDORAK RN, KINNEAR D, SAIBIL F, GROLL A, ARCHAMBAULT A, GILLIES R, VALBERG B, IRVINE J: Low-dose cyclosporine for the treatment of Crohn's disease. N Engl J Med 330:1846-1851, 1994
55. FERRACCIOLI G, GUERRA P, RIZZI V, BARTOLI E: Cyclosporin A increases somatomedin C insulin-like growth factor I levels in chronic rheumatic diseases. J Rheumatol 22:1060-1064, 1995
56. ITALIAN MULTICENTER STUDY GROUP ON CYCLOSPORIN IN PSORIASIS: Cyclosporin versus etretinate: Italian multicenter comparitive trial in sever plaque-form psoriasis. Dermatology 187:S8-S18, 1993
57. FΦRRE Ø, THE NORWEGIAN ARTHRITIS STUDY GROUP: Radiologic evidence of disease modification in rheumatoid arthritis patients treated with cycloosporine. Results of a 48-week multicenter study comparing low-dose cyclosporine with placebo. Arthritis Rheum 37: 1507-1512, 1994
58. HEULE F, MEINARDI MMHM, VAN JOOST T, BOS JD: Low-dose cyclosporine effective in severe psoriasis: A double-blind study. Transplant Proc 20(Suppl 4):32-41, 1988
59. JEWELL P, LENNARD-JONES JE, THE CYCLOSPORIN STUDY GROUP OF GREAT-BRITAIN, IRELAND: Oral cyclosporin for chronic active Crohn's disease: A multicentre controlled trial, Eur J Gastroenterol Hepatol 6:499-450, 1994
60. KRUGER K, SCHATTENKIRCHER M: Comparison of cyclosporin A and azathioprine in the treatment of rheumatoid arthritis-Results of a double-blind multicentre study. Clin Rheumatol 13:248-255, 1994
61. LANDEWÉ RBM, GOEI THÈ HS, VAN RIJTHOVEN AWAM, BREEDVELD FC, DIJKMANS BAC: A randomized, double-blind, 24-week controlled study of low-dose cyclosporine versus chloroquine for early rheumatoid arthritis. Arthritis Rheum 37:637-643, 1994
62. MAHRLE G, SCHULZE HJ, FÄRBER L, WEIDINGER G, STEIGLEDER GK, OTHER MULTICENTER CONTRIBUTORS: Low-dose short-term cyclosporine versus etretinate in psoriasis: Improvement of skin, nail, and joint involvement. J Am Acad Dermatol 32:78-88, 1995
63. TUGWELL P, BOMBARDIER C, GENT M, BENNETT KJ, BENSEN WG, CARETTE S, CHALMERS A, ESDAILE JM, KLINKHOFF AV, KRAAG GR, LUDWIN D, ROBERTS RS: Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis. Lancet 335:1051-1055, 1990
64. BOERS M, VAN RIJTHOVEN AWAM, GOEI THÈ HS, DIJKMANS BAC, CATS A: Serum creatinine levels two years later: Follow-up of a placebo-controlled trial of cyclosporine in rheumatoid patients. Transplant Proc 20(Suppl 4):371-375, 1988
65. ANDERSEN CB, LARSEN S, ELMGREEN J, TVEDE N, ANDERSEN V: Cyclosporine-induced renal morphologic and immunohistologic changes in patients with chronic uveïtis. APMIS 99:576-582, 1991
66. INTERNATIONAL KIDNEY BIOPSY REGISTRY OF CYCLOSPORIN A (SANDIMMUN®) IN AUTOIMMUNE DISEASES: Kidney biopsies in control or cyclosporin A-treated psoriatic patients. Br J Dermatol 122(Suppl 36):95-100, 1990
67. LANDEWÉ RBM, DIJKMANS BAC, VAN DEN WOUDE FJ, BREEDVELD FC, MIHATSCH MJ, BRUIJN JA: Longterm low dose cyclosporine in patients with rheumotoid arthritis: Renal function loss without structural nephropathy. J Rheumatol 23:61-64, 1996
68. MESSANA JM, JOHNSON KJ, MIHATSCH MJ: Renal structure and function effects after low dose cyclosporine in psoriasis patients: A preliminary report. Clin Nephrol 43:150-153, 1995
69. YOUNG EW, ELLIS CN, MESSANA JM, JOHNSON KJ, LEICHTMAN AB, MICHATSCH MJ, HAMILTON TA, GROISSER D, FRADIN MS, VOORHEES JJ: A prospective study of renal structure and function in psoriasis patients treated with cyclosporin. Kidney Int 46:1216-1222, 1994
70. SUND S, FORRE O, BERG KJ, KVIEN TK, HOVIG T: Morphological and functional renal effects of long-term low-dose cyclosporin A treatment in patients with rheumatoid arthritis. Clin Nephrol 41:33-40, 1994
71. SVARSTAD E, HELLAND S, MORKEN T, BOSTAD L, MYKING A, IVERSEN BM, OFSTAD J: Renal effects of maintenance low-dose cyclosporin A treatment in psoriasis. Nephrol Dial Transplant 9:1462-1467, 1994
72. ZACHARIAE H, HANSEN HE, KRAGBALLE K, OLSEN S: Morphologic renal changes during cyclosporine treatment of psoriasis. J Am Acad Dermatol 26:415-419, 1992
73. MIHATSCH MJ, ANTONOVYCH T, BOHMAN SO, HABIB R, HELMCHEN U, NOEL LH, OLSEN S, SIBLEY RK, KEMÉNY E, FEUTREN G: Cyclosporine A nephropathy: standardization of the evaluation of kidney biopsies. Clin Nephrol 41:23-23, 1994
74. FEUTREN G, MIHATSCH MJ: Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. N Engl J Med 326:1654-1660, 1992
75. LUDWIN D, ALEXOPOULOU I: Cyclosporin A nephropathy in patients with rheumatoid arthritis. Br J Rheumatol 32(Suppl 1):60-64, 1993
76. DE BROE ME, STOLEAR JC, NOUWEN EJ, ELSEVIERS MM: 5- Aminosalicylic acid (5-ASA) and chronic tubulointerstitial nephritis in patients with chronic inflammatory bowel disease: Is there a link? Nephrol Dial Transplant 12:1839-1841, 1997
77. STURROCK NDC, LANG CC, STRUTHERS AD: Indomethacin and cyclosporin together produce marked renal vasoconstriction in humans. J Hypertens 12:919-924, 1994
78. MOHER D, OLKIN I: Meta-analysis of randomized controlled trials. A concern for standards. JAMA 274:1962-1964, 1995
79. LELORIER J, GRÉGOIRE G, BENHADDAD AB, LAPIERRE J, DERDERIAN F: Discrepancies between meta-analysis and subsequent large randomized, controlled trials. N Engl J Med 337:536-542, 1997
80. EGGER M, SMITH GD: Meta-analysis. Potentials and promise. BMJ 315:1371-1374, 1997
81. BAILAR JC III: The promise and problems of meta-analysis. N Engl J Med 337:559-561, 1997
82. BENNETT WM, DE MATTOS A, MEYER MM, ANDOH T, BARRY JM: Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy. Kidney Int 50:1089-1100, 1996
83. BOERS M, CROONEN AM, DIJKMANS BAC, BREEDVELD FC, EULDERINK F, CATS A: Renal findings in rheumatoid arthritis: Clinical aspects of 132 necropsies. Ann Rheum Dis 46:658-663, 1987
84. BOERS M: Renal disorders in rheumatoid arthritis. Semin Arthritis 20:57-68, 1990
85. ZACHARIAE H, KRAGBALLE K, HANSEN HE, MARCUSSEN N, OLSEN S: Renal biopsy findings in long-term cyclosporin treatment of psoriasis. Br J Dermatol 136:531-553, 1997